Gheehoe Cheng 🇸🇬

Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.

Future Planet is the impact-led, global venture capital firm built to back growth companies emerging from the founders and science from the worlds top universities. Through a unique series of partnerships and relationships around leading universities, Future Planet has an unrivalled global level of access to entrepreneurs and businesses profitably solving the worlds greatest challenges in Climate Change, Education, Health, Sustainable Growth & Security. Our mission is not simply to deliver excellent returns but to create a lasting impact: by connecting the worlds largest investors with its best minds, we believe we can profitably address the greatest challenges that humanity faces today. The Future Planet Fund has been designed in close conjunction with sophisticated investors in order to provide multi-stage access to start-ups, spin-outs and growing companies, at a scale large enough to suit major sovereign wealth funds and similar institutions.

Our vision is to end the metabolic health crisis. At Veri, we help people improve their metabolic health by helping users understand what to eat. With the Veri mobile app, users scan a wearable glucose sensor to get actionable insights and recommendations on nutrition and their lifestyle habits. We’re a hybrid team of +45 people based around the world but mainly in Helsinki and New York.

Medtrip is a medical concierge platform and medical tourism facilitator. Based in Jakarta, Indonesia, we are determined to help patients in accessing quality medical care abroad. We provide information often hard to discover by international patients to provide recommendation on doctors, hospitals and help them plan their medical journey with medical estimation tool. Our mission is to help patients getting the best medical care possible, anywhere in the world.

Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored. Occuitys IP includes 9granted international patents with a further 5 applications. Our Products Optometry & Ophthalmology: Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202. The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry. Disease Screening Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes. Disease Monitoring Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor. Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.

MedEasy is the no. 1 online pharmacy & healthcare app in Bangladesh. MedEasy app enables you to connect with licensed doctors from 23 specialties and, receive consultations through video calling from anywhere. We also provide doorstep diagnostic services.

Tenity is a global innovation powerhouse shaping the future of finance and technology. With hubs across Europe and Asia, Tenity blends venture capital, open innovation and global ecosystem access to create value that compounds. Since launch, it has partnered with over 65 institutions, supported 1,600+ startups, and runs innovation programs in 15+ countries.

The Good Seat has developed a solution that aggregates the offers from major ride-hailing & taxi platforms worldwide and gives access to their data in real time along with a comparator system. We provide this technology through different product types (white-label API, mobile application, website, dashboard) to companies which need it - experience platforms (mobility, travel, hospitality, event) and large accounts. We enable these actors to meet the last-mile challenge, improve customer experience through innovative digital services, generate ancillary revenues or reduce their mobility budget as well as their carbon footprint. In short, we enable the MaaS to develop. Want to know more ? Check out our website or send us a message !

Findr - The business matching platform for decision-makers 9x faster than traditional methods, Findr reduces the time and money spent securing that all-important Discovery call with a vetted decision-maker at a target business. 🏁 Get started - Directly access vetted decision-makers 🤝 Get matchmaking - Browse profiles of fellow decision-makers 📞 Hold discovery calls - Request a Discovery call when you spot a match Sector and size agnostic, we’re helping 500+ decision-makers, from startups to enterprises including Mastercard, Uber and Experian, reach their target decision-makers. Don’t just take our word for it, here’s what our members have said: 🔶 Blink Payment - "We’d been trying to contact a company for weeks and weeks. Once they were on Findr we spoke with the right team in a day.” 🔶 Deliveroo - "Findr helps us to discover and engage with a diverse range of businesses seeking to develop new and innovative partnerships." 🔶 eToro - "Having direct access to key decision makers within global businesses across a range of industries allows us to explore new, innovative opportunities at a much faster pace."

Mastercard Lighthouse is the leading partnership platform in the Nordics & Baltics. Unlike typical accelerators, the Lighthouse platform is free and entirely focused on creating partnerships between promising startups and large corporations. We do this through two three-month programs:   Lighthouse FINITIV: A search and partnership program focused on finding the next fintech unicorn. Our goal is to strengthen the financial services ecosystem by pairing the energy and innovation of Fintechs with the stability and distribution at large corporates. Lighthouse MASSIV: A partnership program focused on the UN SDG's and dedicated to help one billion people live more prosperous and secure lives by 2025 - by helping impact tech companies scale globally through partnerships with large organizations. Applications for the programs are open. Apply via: https://mclighthouse.com/

Ripple enables energy consumers around the world to part own large scale wind farms and solar parks and have the clean, low cost electricity they produce supplied to their homes via the grid. The simple, affordable way to act on climate change. Our utility partners supply the electricity from the wind farms and solar parks to their owners’ homes via the grid. Ripple puts the power to act on climate change in people’s hands. We enable people to create the clean energy future they want to see. Simply and easily.

Choise.com is a MetaFi (CeFi/DeFi) ecosystem based on Crypterium CeFi solutions and Charism DeFi protocol, that reinvents how protocols operate with CeFi, reduces commissions up to 50 times and unlocks cross-chain high yield to 100 mln CeFi users. Contact: support@choise.com Join us on Telegram: https://t.me/choise_com

PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health. The company’s first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.

Arival is a licensed and regulated digital bank geared towards a new generation of global businesses and startups. Banks are old. Were not.™

In response to the increasing challenge facing the healthcare sector, a group of renowned scientists, medical doctors, entrepreneurs and academic figures is launching a unique endeavour: healthbank. At healthbank we are building the world’s first people-owned health data transaction platform. healthbank will connect data sources from all facets of the healthcare ecosystem and reward participants for sharing their data for research purposes. Based in Switzerland, healthbank will leverage the advantages of Swiss neutrality, trust, and data privacy to enable users, researchers, and organisations with large data sets, to unlock the value of health and medical data on our independent, global transaction platform. healthbank is organised as a Swiss Cooperative that is fully owned and governed by its members. Its purpose is to empower users to store, access, manage and share and gain returns from their personal health information according to their needs. Our vision is to play an active role in raising people’s awareness of health beyond illness, by providing self-governed, user-centric participative platforms and value-added services that enable health data accessibility, protection and rewards.

Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.

Future Planet is the impact-led, global venture capital firm built to back growth companies emerging from the founders and science from the worlds top universities. Through a unique series of partnerships and relationships around leading universities, Future Planet has an unrivalled global level of access to entrepreneurs and businesses profitably solving the worlds greatest challenges in Climate Change, Education, Health, Sustainable Growth & Security. Our mission is not simply to deliver excellent returns but to create a lasting impact: by connecting the worlds largest investors with its best minds, we believe we can profitably address the greatest challenges that humanity faces today. The Future Planet Fund has been designed in close conjunction with sophisticated investors in order to provide multi-stage access to start-ups, spin-outs and growing companies, at a scale large enough to suit major sovereign wealth funds and similar institutions.

Our vision is to end the metabolic health crisis. At Veri, we help people improve their metabolic health by helping users understand what to eat. With the Veri mobile app, users scan a wearable glucose sensor to get actionable insights and recommendations on nutrition and their lifestyle habits. We’re a hybrid team of +45 people based around the world but mainly in Helsinki and New York.

Medtrip is a medical concierge platform and medical tourism facilitator. Based in Jakarta, Indonesia, we are determined to help patients in accessing quality medical care abroad. We provide information often hard to discover by international patients to provide recommendation on doctors, hospitals and help them plan their medical journey with medical estimation tool. Our mission is to help patients getting the best medical care possible, anywhere in the world.

Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored. Occuitys IP includes 9granted international patents with a further 5 applications. Our Products Optometry & Ophthalmology: Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202. The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry. Disease Screening Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes. Disease Monitoring Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor. Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.